BREAKING NEWS: Stocks Start December With More Gains
Toggle navigation
About Us
Who We Are
About Bernie Schaeffer
Our Newsroom
FAQ
Contact Us
Corrections
Ethics & Fact Checks Policy
Market News
Sign Up for Free Market Newsletters
Opening View
Midday Market Check
Market Recap
View All Free Subscriptions
Schaeffer's Volatility Scorecard
Featured Publication
From the Top
Monday Morning Outlook
Indicator of the Week
Editor's Picks
View All
Trading Analysis
Best & Worst Stocks
Earnings Preview
Investor Sentiment
Quantitative Analysis
Technical Analysis
VIX & Volatility
View All
Stock Options
Intraday Options Activity
Most Active Options
Trade Postmortems
Options Recommendations
View All
Trading Education
Strategies & Concepts
Expectational Analysis
View All
Market News
Buzz Stocks
Stocks on the Move
Analyst Update
5 Minute Market Rundown
Stock Market Podcasts
View All
Daily Market Newsletters
Opening View
Midday Market Check
Market Recap
View All
Trade Alerts
All Trading Services
Most Popular Services
Elite Trader
Quick-Hit Trader
Lightning Trader
Ultimate Trader
View All
Directional Trading
Options Under $5
Leverage
Weekly Options Trader
Event Trader
PowerTrend
Schaeffer's Players
Overnight Trader
View All
Advanced Trading Alerts
Wealthbuilder
Premium Trader
Hedge Hunter
Volatility Trader
Weekly Volatility Trader
View All
Weekend Alert
Weekend Player
Weekend Trader Alert
Expiration Week Countdown
Weekly Options Countdown
View All
Newsletter Trading Services
Master Portfolio
The Option Advisor
Schaeffer's Daily Bulletin
View All
Courses & Education
Getting Started with Options
View All
Options 101
Deals
Deal of the Week
Broker Center
Free Trial
Log-In
Search
Buzz Stocks: Mobileye NV, Activision Blizzard, Inc., and Aquinox Pharmaceuticals Inc
Today's stocks to watch include Mobileye NV (MBLY), Activision Blizzard, Inc. (ATVI), and Aquinox Pharmaceuticals Inc (AQXP)
Andrea Kramer
Nov 3, 2015 at 9:29 AM
KING
|
AQXP
|
ATVI
|
MBLY
Today's stocks to watch include Mobileye NV (MBLY), Activision Blizzard, Inc. (ATVI), and Aquinox Pharmaceuticals Inc (AQXP)
U.S. stocks are set to
take a breather
after Monday's surge.
Among the equities in focus are driver-assistance software concern
Mobileye NV (NYSE:MBLY)
, video game maker
Activision Blizzard, Inc. (NASDAQ:ATVI)
, and biotech
Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)
.
MBLY
is pointed 3% higher ahead of the bell, after the firm reported stronger-than-expected
third-quarter earnings and sales
. What's more, a short squeeze could add fuel to the shares' fire. Short interest accounts for nearly 20% of Mobileye NV 's total available float, representing 11 sessions' worth of pent-up buying demand, at the stock's average pace of trading. However, will it be enough to boost MBLY above its 10-week moving average? This trendline -- currently docked at $47.63 -- has stifled MBLY's rebound attempts since the August swoon. On Monday, MBLY settled at $45.54.
ATVI
is
fractionally lower in pre-market trading, as traders digest the "Call of Duty" producer's third-quarter earnings and plans to
buy "Candy Crush" maker King Digital Entertainment PLC (NYSE:KING)
for $5.9 billion. Heading into earnings, Activision Blizzard, Inc. was
surrounded by pessimism
. It would take about seven sessions to repurchase all the shorted ATVI shares, at the equity's average pace of trading, and the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.59 stands higher than 84% of all other readings from the past year. In other words, near-term options traders have rarely been more put-biased. Still, ATVI has already shaken off most of its post-earnings losses. Should the stock turn higher, a mass exodus of bears could help ATVI extend its year-to-date lead of more than 71.5%. Yesterday, ATVI finished at $34.57 -- within a point of
record-high territory
.
AQXP
is poised for a 10% plunge out of the gate, after the firm's
experimental skin drug failed a mid-stage study
. Aquinox Pharmaceuticals Inc said it will now focus on further development of AQX-1125, its
experimental bladder drug that caused much fanfare last month
, and said it's looking forward to its Dec. 8 meeting with the Food and Drug Administration (FDA) about "pivotal trial designs." On the charts, AQXP has been stagnating in the $15-$20 range for the past few weeks, closing at $16.36 yesterday. Should the stock take a turn for the worse and breach the lower end of this rail, it could be vulnerable to downgrades. Currently, five out of six analysts offer up "buy" or better opinions.
Get the skinny on
all
the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!
Follow @Schaeffers
*SPONSORED CONTENT*
How to collect 1 dividend check every day for LIFE
Did you know you could collect 1 dividend check every day the market is open? You could also do it starting with just $605!
For me, I'm collecting 70 dividend checks every quarter
…which averages around 1.1 dividend checks every business day. There's no trading behind this... no penny stocks or high-risk investments. All you do is buy and hold and you're set. There's no set up required either. If you start buying the dividend stocks I show you today... you could collect 1 dividend per day starting as early as this week.
Click here for all the details.
*SPONSORED CONTENT*
Don't Miss A Single Market Update!
Don't Miss Any Updates!
Get our unique market analysis and news delivered straight to your inbox
Unique market analysis and news directly in your inbox
Subscribe to...
Opening View
:
critical trading analysis before the market opens
before the market opens
Midday Market Check
:
midday check-in on the day’s trading session
midday check-in
Market Recap
:
complete trading day summary after the market close
after the market close
Monday Morning Outlook
:
analyzing the current market climate
current market analysis
5-Minute Market Rundown
:
quick rundown of last week’s trading sessions
last week’s rundown
Email Address:
Click to add
(?)
Submit
LIVE Trading Closeout Tracker
Weekly Options Countdown Plus
RBLX
Call
+201%!
Profit taken 12/1
Volatility Trader
ENPH
Straddle
+157%!
Profit taken 12/1
Weekly Options Trader
COIN
Call
+269%!
Profit taken 11/22
Leverage Trader
TOL
Call
+119%!
Profit taken 11/24
Option Advisor
CBOE
Call
+100%!
Profit taken 11/21
Options Under $5
TOL
Call
+223%!
Profit taken 11/14
Expiration Week Countdown
DASH
Call
+203%!
Profit taken 11/14
Expiration Week Countdown
CVNA
Call
+200%!
Profit taken 11/14
PowerTrend
ANF
Call
+161%!
Profit taken 11/14
In The Money Countdown
AMD
Call
+100%!
Profit taken 11/10